---
figid: PMC5445933__nihms857850f3
figtitle: Main pathways altered in GEMMs of cutaneous melanoma
organisms:
- Rat sarcoma virus
- Avian leukosis virus
- Homo sapiens
- Mus musculus
- Diaporthe sclerotioides
pmcid: PMC5445933
filename: nihms857850f3.jpg
figlink: /pmc/articles/PMC5445933/figure/F3/
number: F3
caption: The main pathways altered in GEMMs of cutaneous melanoma. The principal oncogenic
  modifications introduced in mouse models of melanoma involve the activation of RAS/RAF/MEK/ERK
  and phosphoinositide-3 kinase (PI3K) pathways, the most frequently altered pathways
  in human melanomas. Stimulation of receptor tyrosine kinases (RTK) by binding of
  growth factors (GF) leads to the activation of these pathways resulting in induction
  of proliferation and/or migration and invasion. Alternatively, RAS/RAF/MEK/ERK pathway
  can be induced by direct activation of RAF proteins by G protein-coupled receptors
  (GPCR). Deletion of the tumor suppressor phosphatase and tensin homolog deleted
  on chromosome 10 (PTEN) can also indirectly activate PI3K pathway. In addition,
  cell cycle progression can be induced by the oncogenic activation of cyclin-dependent
  kinase 4 (CDK4) or the inactivation of the tumor suppressors cyclin-dependent kinase
  inhibitor 2A (CDKN2A) or p53. The specific allelic modifications available in mouse
  models of melanoma are highlighted in red (also see ).
papertitle: Genetically Engineered Mouse Models of Melanoma.
reftext: Eva PÃ©rez-Guijarro, et al. Cancer. ;123(Suppl 11):2089-2103.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9634869
figid_alias: PMC5445933__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5445933__F3
ndex: 296628df-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5445933__nihms857850f3.html
  '@type': Dataset
  description: The main pathways altered in GEMMs of cutaneous melanoma. The principal
    oncogenic modifications introduced in mouse models of melanoma involve the activation
    of RAS/RAF/MEK/ERK and phosphoinositide-3 kinase (PI3K) pathways, the most frequently
    altered pathways in human melanomas. Stimulation of receptor tyrosine kinases
    (RTK) by binding of growth factors (GF) leads to the activation of these pathways
    resulting in induction of proliferation and/or migration and invasion. Alternatively,
    RAS/RAF/MEK/ERK pathway can be induced by direct activation of RAF proteins by
    G protein-coupled receptors (GPCR). Deletion of the tumor suppressor phosphatase
    and tensin homolog deleted on chromosome 10 (PTEN) can also indirectly activate
    PI3K pathway. In addition, cell cycle progression can be induced by the oncogenic
    activation of cyclin-dependent kinase 4 (CDK4) or the inactivation of the tumor
    suppressors cyclin-dependent kinase inhibitor 2A (CDKN2A) or p53. The specific
    allelic modifications available in mouse models of melanoma are highlighted in
    red (also see ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hgf
  - Met
  - Grm1
  - Ret
  - Gpbar1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Braf
  - Braf-rs1
  - Pik3r1
  - Pten
  - Mdk
  - Akt1
  - Mtor
  - Ephb2
  - Mapk1
  - Gabrg2
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Cdk2
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Mdm2
  - Trp53
  - Pcolce
  - S100a9
  - Lamtor2
  - HGF
  - IL6
  - SOS1
  - GRM1
  - RET
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - CCND1
  - CCND2
  - CCND3
  - WARS1
  - CDKN2A
  - H3P10
  - CDK2
  - CCNA1
  - CCNA2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MDM2
  - TP53
  - TP63
  - TP73
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
